<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 2 Issue 4</issue_number>
<issue_period>2011 (October - December)</issue_period>
<title>Process Validation Of Fluconazole </title>
<abstract>Validation is the act of demonstrating and documenting that a procedure operates effectively. The U.S Food and Drug Administration (FDA) guidelines state that the process validation is the established documented evidence which provides a high degree of assurance that specific process.Fluconazole is a triazole antifungal drug used in the treatment and prevention of superficial and systemic fungal infections. In a bulk Powder form, it appears as a white crystalline powder, and it is very slightly soluble in water and soluble in alcohol. It is designated as 2,4-difluoro-bis(1H-1,2,4-triazol-1-ylmethyl) benzyl alcohol with an empirical formula of C lessThan sub greaterThan 13 lessThan /sub greaterThan H lessThan sub greaterThan 12 lessThan /sub greaterThan F lessThan sub greaterThan 2 lessThan /sub greaterThan N lessThan sub greaterThan 6 lessThan /sub greaterThan O and molecular weight 306.3. </abstract>
<authors>Bodavula Samba Siva Rao K.Raveendra Babu   And D.Praveen Kumar</authors>
<keywords>Onychomycosis, Candida, Tinea corporis, Antifungal</keywords>
<pages>461-471</pages>
</article>
</Journal>
